Original effective, safe technique of obtaining platelet rich plasma by centrifugation of the blood plasma in modified syringe containers by Chetverikov, S.
Original Research Article:
full paper
(2019), «EUREKA: Health Sciences»
Number 1
3
Medicine and Dentistry
ORIGINAL EFFECTIVE, SAFE TECHNIQUE OF OBTAINING 
PLATELET RICH PLASMA BY CENTRIFUGATION OF THE 
BLOOD PLASMA IN MODIFIED SYRINGE CONTAINERS
Sergiy Chetverikov
Surgery department No. 4 with oncology course
Odessa National Medical University
2 Valichovskiy lane, Oddesa, Ukraine, 65082
dmitriyatanasov@gmail.com
Dmitro Atanasov
Surgery department No. 4 with oncology course
Odessa National Medical University
2 Valichovskiy lane, Oddesa, Ukraine, 65082
dmitriyatanasov@gmail.com
Abstract
The aim: to develop, substantiate an effective and safe technology for producing PRP (platelet rich plasma). To quantify the 
substrate based on the recommended centrifugation protocols.
Materials and methods: the effectiveness of the original harvesting protocol was evaluated by quantifying the number of 
platelets. The proposed technique is formed basing on the basic principles of double centrifugation of whole blood in test tubes with 
anticoagulant, separation with the release of a plasma layer with a high content of platelets.
The centrifuging mode for quantifying the effectiveness of the substrate was selected according to recommendations based 
on a study confirming maximum efficiency (160 g×10 min + 250 g×15 min).
For quantitative evaluation, blood was collected from 10 healthy volunteers (7 men, 3 women) with an average age of 
26.0±2.6, and centrifuged in standard mode. Quantitative evaluation of platelets of whole blood and the obtained PRP substrate was 
carried out with a semi-automatic analyzer.
Results: the proposed technique is based on the use as a container for centrifuging a syringe with a LuerLock design, which is 
hermetically sealed with a congruent plug, adapted by the external size of the centrifuge rotor bowl. Phase selection after centrifuga-
tion was performed by aspiration of the syringe contents after centrifugation is performed through a three-way valve. The substrate 
was obtained by repeated centrifugation of the contents, which allows obtaining a variable volume and platelet concentration in PRP. 
The amount of platelets (PLT) of whole blood is 227.0±57.0 thousand per ml. PLT PRP 945.0±279.0 thousand per ml.
Conclusions: the proposed method of separation of whole blood with the release of the platelet rich plasma demonstrates 
high efficiency, which corresponds to the level of increasing the number of platelets in reducing the volume at the level of the best 
ready-made solutions.
The equipment is economical and does not require highly specialized equipment and consumables. The proposed technique 
provides a wide choice to the performer in the received volume of the substrate.
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1. Introduction
At the present stage of development of medicine, platelet rich plasma (PRP) – based plasma 
products, that have found application and have become firmly established in clinical practice in 
many medical fields [1, 2]. The stimulating effect on post-traumatic, as well as age-related skin 
changes ensured the popularity and widespread use of PRP in reconstructive, aesthetic surgery, 
and cosmetology [3, 4]. Most of the thematic publications prove the high effectiveness of PRP in 
surgical dentistry, orthopedics [4, 5]. In addition, a significant number of publications use PRP in 
the practice of gynecologists, urologists, cardiovascular surgeons [6, 7].
The overwhelming majority of authors state the safety and high efficiency of the techniques. 
Given that the substrate is autologous, subject to the technology of obtaining leveled the risk of 
allergic, infectious complications. The safety of the substrate has been proven in the publications of 
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many authors [8, 9]. However, the effectiveness according to different authors varies significantly 
and depends on the quantitative characteristics, the main and affordable rapid assessment of which 
is the number of platelets per unit volume [10, 11]. This indicator determines the compliance of PRP 
with standardized criteria as well as the expected clinical effect. There are various PRP production 
systems on the market. In some cases, the figures declared by manufacturers have not been con-
firmed in practice [12]. In all cases, whole blood in a container with an anticoagulant is subjected 
to centrifugation with phase separation and subsequent separation of red blood cells and part of 
the plasma volume [12, 13]. Separation of whole blood is achieved by obtaining plasma with an 
increased number of platelets. Fundamental differences were noted in the design of containers for 
sampling, centrifugation, as well as the technology of selection of the separated phases. The most 
common option is simple tubes, standard forms of the type PRGF EndoRet (Plasma Rich in Growth 
Factors) from the Biotechnology Institute, Spain, the main drawback of which is the manual se-
lection with a syringe, which requires certain skills in performance [12]. The kits containing the 
helium separator of fractions of the RegenLab type (Switzerland) have the disadvantages of high 
complexity, high cost of the kit, as well as significant losses in platelet count, which is determined 
by the separation technology itself [12, 14]. Other systems for obtaining PRP differing in the design 
of the container with a more complex device, allowing the selection of separated phases to be per-
formed according to the standard procedure are less demanding on the skills of the contractor, but 
they are expensive [15, 16]. Thus, it is difficult to isolate the optimal variant of the PRP production 
system taking into account the need for volume, as well as the substantial cost of centrifuges and 
consumable sets for most systems [15, 17].
2. Aim of the work
Develop a technology for obtaining PRP with a safe and highly efficient procedure that 
allows obtaining a variable volume of the substrate using available consumables that will provide 
high economic efficiency.
3. Materials and methods
The results of the assessment of quantitative indicators of compliance of the substrate of 
plasma rich with platelets obtained by the original method of compliance with standard require-
ments were analyzed.
The proposed technique are basing on the basic principles of dual centrifugation of whole 
blood in test tubes with an anticoagulant, separation with the release of a plasma layer with a high 
content of platelets.
In a patient by venipuncture of the peripheral or central vein, blood is collected in a syringe 
with a LuerLock attachment mechanism filled in 10 % of the volume with a solution of the antico-
agulant CITRAT glucose solution A (ACD-A) and filled to the full volume with the patient’s blood 
after which the syringe is sealed under aseptic conditions tightly and congruently to LuerLock stub 
CombiStopper. Refinement of the shape of the container syringe was carried out sharply and did not 
require compliance with the strict conditions of asepsis due to the fact that the system was closed 
during these stages of harvesting. The selection of centrifuged phases was carried out through a 
three-way tap of Discofix C in compliance with the aseptic conditions.
In previously published studies, the maximum efficiency of platelet concentration was 
demonstrated in double centrifugation with a 160g×10min + 250g×15min mode [18]. In choosing 
the centrifugation protocol, they relied on these indicators, adapting the rate of acceleration to the 
rotor design of the centrifuge used. A subjective assessment of the separation of the buffer layer 
was performed based on the nature of the distribution of the phases in standard tubes with similar 
conditions.
The clinical stage of the work was performed in the conditions of the surgical department 
of the Center for Reconstructive Restorative Medicine and the Department of Surgery No. 4 of the 
ONMEDU.
For quantitative evaluation, blood was collected from 10 healthy volunteers (7 men, 3 wom-
en) with an average age of 26±2.6 years, centrifuged in a Hettich Rotorfix 32A centrifuge (Ger-
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many) with a rotor adapted for Arthrex ACP containers. Estimation of the platelet count of whole 
blood and the obtained PRP substrate was estimated using a Micro-CC 20 semi-automatic hema-
tology analyzer (HTI USA). Statistical processing was performed using standard MS Office Excel 
2013 algorithms. The confidence interval was determined by calculating Student’s t test (p<0.05).
4. Results 
Based on the biological inertness and availability of congruent components, we determined 
the syringes with the connector of the LuerLock design as the optimal container for centrifuging.
Formulated protocol:
In a patient by venipuncture of the peripheral or central vein, blood is collected in a syringe 
with a LuerLock attachment mechanism filled in 10 % of the volume with a solution of the antico-
agulant CITRAT glucose solution A (ACD-A) and filled to the full volume with the patient’s blood 
after which the syringe is sealed under aseptic conditions tightly and congruently to LuerLock stub 
CombiStoper.
In order to reduce the size of the “syringe container”, it is proposed to remove the excess 
length of the piston with the formation of a uniformly flat surface on which the container will be 
supported during the centrifugation process. Removing excess piston length does not require asep-
tic conditions and can be done with a sharp scalpel or forceps. In order to adapt the diameter of the 
“syringe container”, it is additionally necessary in a similar way to remove the excess surface of 
the finger rest.
By the method described above, the patient’s blood was collected. In order to reduce the size 
of the “syringe container”, it has been proposed to remove the excess length of the piston with the 
formation of a uniformly flat surface upon which the container will be supported during the centrif-
ugation process (Fig. 1). Removing excess piston length does not require aseptic conditions and can 
be done with a sharp scalpel or forceps. In order to adapt the diameter of the “syringe container”, 
it is additionally necessary in a similar way to remove the excess surface of the finger rest (Fig. 1).
Fig. 1. Type of adaptation of the external dimensions of the syringe after the material is taken,  
the combi-stopper closes
The resulting “syringe container” should receive the dimensions corresponding to the in-
ternal dimensions of the centrifuge container used in this case. Thus, for most centrifuges used in 
laboratory and clinical practice, it is advisable to use syringes of 10 ml, in some cases when using 
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rotors of centrifuges with large-diameter bowls, it is advisable to use syringes of 20 ml. The limit-
ing conditions for the selection of centrifuges is the possibility of observing a controlled rotational 
speed in the range of 100–250g and the presence of a horizontal rotor with freely deflected cups. 
After placing the “syringe containers” in the rotor cups installed in the centrifuge, centrifuging 
is performed in pairs with an acceleration of 160 g in the range from 12 to 16 min, the so-called 
“soft spin” [12, 18]. Time may vary depending on the conditions of the procedure (hematocrit level, 
which was determined before, temperature and humidity of the air in the room). After the first cen-
trifugation, the “syringe containers” are carefully removed and placed in a stand vertically.
The result of the first stage of centrifugation is blood distribution with separation of the 
erythrocyte fraction deposited from the side of the syringe piston, the blood plasma remains su-
perficially in the container and the thrombolic leukocyte layer located in the buffer zone between 
the erythrocyte layer and plasma and under the correct mode of centrifugation conditions selection 
looks gradiently over 20 % of the total height of the plasma column. After the combi-stopper is 
removed, the corresponding end of the traveling crane Discofix C is attached to each of the syringes 
while maintaining a strictly vertical orientation in the LuerLock connector. The rotary mechanism 
of Discofix is set to the position of blocking free connector and combines both syringes with each 
other. An empty syringe should be installed with the piston at 0.
 Carrying out the movement of the piston of an empty syringe “to itself” by a controlled 
movement, the plasma layer is aspirated together with the buffer layer through a three-way valve 
(Fig. 2). This procedure is performed with each on the use of syringes alternately, with the appro-
priate addition of a syringe aspiration of plasma with a buffer layer to the full volume. Syringes are 
closed with combi-stopper plugs. For example: using 4 syringes with a volume of 20 ml at the first 
stage of centrifugation, plasma with a buffer layer in each syringe will take approximately 11 ml, 
that is, from 4 syringes it can be taken in 2 syringes 20 ml used “syringe containers” with erythro-
cyte layer and combi-stoppers are disposed of.
Fig. 2. The separation of the erythrocyte layer. Selection by aspiration of the separated layer: 
plasma + buffer layer
It is important at this stage to maintain the level of aspiration with the maximum approxi-
mation to the erythrocyte layer. The need for manual control of the level of aspiration is one of the 
key disadvantages of this method of separation of blood components. This disadvantage can be 
partially eliminated due to the use of a controlling mechanism with a free piston moving along the 
thread with a wide pitch in the coupling that is attached to the body of the “syringe container”. By 
moving the movable piston along the thread, a well-controlled, metered advancement of the piston 
of the “syringe container” is performed, which allows a more precise determination of the level of 
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separation of the erythrocyte layer and reduces the risk of excessive red blood cell or insufficient 
collection of the buffer layer. Having obtained syringes in which plasma with a buffer layer is se-
lected, they are followed by a similar procedure — removing the excess length of the piston and 
the finger stops, providing the shape of the centrifuge rotor adapted to the internal size of the rotor 
container. Syringes containers are centrifuged in pairs. The purpose of the second stage of centrif-
ugation is the concentration of the platelet layer.
Centrifugation is performed with a high acceleration of – 250 g for – 10–15 minutes – the 
so-called “hard spin”. It is possible to place “syringe containers” vertically in a centrifuge bowl – 
a combi-stopper – then, as a result of centrifugation, the plasma fraction enriched with platelets 
will occupy one third of the volume on the piston side (Fig. 3). It is necessary to aspirate 2/3 of the 
so-called “poor platelet plasma” through the Diskix, this plasma is not used. 1/3 of the remaining 
volume is plasma rich with platelets. Similarly, through a three-way valve, platelet-rich plasma is 
aspirated into a syringe of the LuerLock design. In order to activate platelet-enriched plasma, it 
is advisable to use a widely available CaCl2 solution of 10 % in a ratio of 10 % of the total plasma 
volume of platelet-rich as the activating agent [20]. The volume, administration of the activator, as 
well as the choice of another activating agent, may vary depending on the potential application and 
the need for exposure or long-term use of the drug platelet-rich plasma.
Fig. 3. Result of the 2nd centrifugation – Hard Spin. PRP in ⅓ basal volume
This method assumes observance of aseptic conditions when performing the procedure only 
in the connector parts of the syringes and the disc reflux concerning blood and its components 
and does not require general sterility, which is sterilization of the centrifuged part of the rotor 
(rotor cups) and can be performed in the operating unit clinical laboratory. PRP suitable for use 
in non-sterile syringes may be aspirated with a sterile syringe with a variable needle and, after 
changing the needle, used under aseptic operating conditions. In order to monitor the effectiveness 
of concentration and determine the direct quality of PRP, it is advisable to determine the plate-
let count and hemoglobin level using standard laboratory analyzers used in clinical laboratory 
practice. We offer for use semi-automatic analyzers. In order to achieve an appropriate quality of 
centrifugation and fractionation, an important criterion is to preserve the maximum number of 
platelets in the final substrate. Another criterion is the minimum level of hemoglobin (up to 5 g/l), 
which is an indicator of sufficient precision of the detachment of the buffer layer at the stage of the 
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first centrifugation. For example: with a patient’s hemoglobin level of 130 g/l and a platelet level of 
250 thousand/μl at a concentration of 5 times (that is, about 15 ml of PRP obtained from 72 ml of 
whole blood collected from the patient) analyzer in 1 million µl. A sufficient quantitative indicator 
of the qualitative detachment of the buffer layer will be the level of hemoglobin of the final sub-
strate – PRP at a level of up to 5 g/l.
The results of a quantitative assessment of the concentration of platelets in the whole blood 
of the subjects as well as in the PRP substrate harvesting technique described above are presented. 
The results are shown in Table 1.
Table 1
Assessment of platelet levels of whole blood and the resulting PRP study group
The number of studied
Initial average platelet 
level of whole blood, 
thousand in ml
Centrifuging mode
The average number 
of platelets in PRP 
thousand in ml
Multiplication factor
10 227.0±57.0 160g×10min+
+250g×15min 945.0±279.0 4.16
5. Discussion
The proposed protocol for obtaining plasma enriched with platelets is characterized by the 
use of consumables widely available in clinical practice and makes it possible to be adapted to 
many types of centrifuges and their rotors, which makes it possible to consider the proposed tech-
nology to be fundamentally more accessible in comparison with the analogues on the market.
For centrifuging, most rotor centrifugal centrifuges are adapted, equipped with rotary cups 
rotors, which are widely used in clinical and laboratory practice. As a consumable, the method 
requires an appropriate plasma-rich platelet volume that requires a number of syringes with a Luer-
Lock attachment. For example, to get 16 ml of PRP you need 7 syringes 20.0. A combi-stopper plug 
is used for each syringe for each centrifugation step. With careful performance and observance of 
aseptic conditions in the connectors during the procedure, it is possible to use one three-way valve 
disc fixes. The ACD-A solution is used as an anticoagulant available and does not require special 
storage conditions and can be used in various packing volumes, provided it is stored under aseptic 
conditions during storage and used.
A solution of CaCl2 10 %, which is used as an activator is widely available [19]. In addition, 
the proposed method allows a differentiated approach to the procedure given the required volume 
of PRP (from 2 ml to 16 ml per procedure), which is convenient in medical practice considering 
the wide range of tasks for the application of the substrate. The possibility of obtaining significant 
amounts of PRP in comparison with standard methods is an important improvement that allows us 
to recommend a technique for use in general surgical practice, which often requires a significant 
amount of PRP-10 ml or more.
6. Conclusions
1. The proposed method of separation of whole blood with the release of the plasma rich 
with platelets demonstrates high efficiency, which corresponds to the level of increasing the num-
ber of platelets in reducing the volume at the level of the best ready-made solutions.
2. The equipment is economical and does not require highly specialized equipment and 
consumables.
3. The proposed technique provides a wide choice to the performer in the received volume 
of the substrate.
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